Stock Information
Jazz Pharmaceuticals PLC (JAZZ)
Ticker Symbol: JAZZ
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $11,546.59 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -6.0697
Revenue (TTM): $67.49 M
Dividend Yield: N/A%
ROE: -9.25%
Latest News
-
Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate
Tue, Mar 3, 2026 8:24 PM
-
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Tue, Mar 3, 2026 3:52 PM
-
Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know
Mon, Mar 2, 2026 2:15 PM
-
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Mon, Mar 2, 2026 11:10 AM
-
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Mon, Mar 2, 2026 11:01 AM
-
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now?
Sun, Mar 1, 2026 9:27 AM
-
Jazz Pharmaceuticals’ Record Revenue And Cancer Data Raise Durability Question
Sat, Feb 28, 2026 10:13 PM
-
Why Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Sales But Full-Year Loss
Sat, Feb 28, 2026 11:13 AM
-
Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock?
Fri, Feb 27, 2026 2:54 PM
-
This Jazz Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
Fri, Feb 27, 2026 2:03 PM
Key Financials
Financial data not available